New trial aims to test a non-invasive treatment for early-stage liver cancer

new trial aims to test a non invasive treatment for early stage liver cancer

Sumary of New trial aims to test a non-invasive treatment for early-stage liver cancer:

  • Researchers are set to trial a non-invasive treatment for inoperable early-stage liver cancer, thanks to an injection of over $2 million in federal government funding.
  • Led by Professor Alan Wigg from Flinders University’s College of Medicine and Public Health, the trial aims to test stereotactic ablative body radiotherapy (SABR), a non-invasive technique that enables high radiation doses to be delivered very precisely.
  • “Stereotactic ablative body radiotherapy on the other hand is a relatively new radiation technique that has already been used successfully to treat a number of other cancers, but it is not yet widely used to treat cancers of the liver.
  • ” Professor Alan Wigg, College of Medicine and Public Health, Flinders University Related StoriesThe researchers say with increasing rates of liver cancer across Australia, it’s vital that the best treatment is proven and applied.

Want to know more click here go to source.

From -

Close

Languages